Jeff Yass’s Finch Therapeutics Group, Inc. Common Stock FNCH Stock Holding History

Jeff Yass’s Portfolio FNCH Stock Details FNCH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-59,028	Closed	-$155K	–	13610
2024 Q1	$155K	Hold	59,028	–	–	﹤0.01%	10873
2023 Q4	$213K	Hold	59,028	–	–	﹤0.01%	10559
2023 Q3	$301K	Hold	59,028	–	–	﹤0.01%	9342
2023 Q2	$504K	Sell	59,028 -1	-0%	-$10	﹤0.01%	8299
2023 Q1	$696K	Hold	59,029	–	–	﹤0.01%	7743
2022 Q4	$850K	Hold	59,029	–	–	﹤0.01%	6539
2022 Q3	$2.96M	Hold	59,029	–	–	﹤0.01%	4124
2022 Q2	$5.03M	Hold	59,029	–	–	﹤0.01%	3180
2022 Q1	$8.91M	Hold	59,029	–	–	﹤0.01%	2703
2021 Q4	$17.7M	Hold	59,029	–	–	﹤0.01%	2009
2021 Q3	$23M	Buy	+59,029	New	+$25.2M	﹤0.01%	1831

Other funds holding FNCH

LSAG

Lake Street Advisors Group Portsmouth, New Hampshire $2.17B AUM 16.99% 1-Year Est. Return

Jeff Yass's FNCH Position: Q2 2024 in Review

Jeff Yass sold out of Finch Therapeutics Group, Inc. Common Stock (FNCH) in Q2 2024, closing a stake of 59,028 shares — an estimated $155K sold.

Jeff Yass first reported a position in FNCH in Q3 2021 and held it in 11 quarters. The position peaked at $23M in Q3 2021. 1 fund tracked by Wall St. Rank holds FNCH as of Q2 2024.

Jeff Yass reported no remaining Finch Therapeutics Group, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Jeff Yass sold 59,028 Finch Therapeutics Group, Inc. Common Stock shares in Q2 2024, an estimated $155K.
Jeff Yass first reported a position in Finch Therapeutics Group, Inc. Common Stock in Q3 2021 and held it in 11 quarters.
Jeff Yass's Finch Therapeutics Group, Inc. Common Stock position peaked at $23M in Q3 2021.
1 fund tracked by Wall St. Rank held Finch Therapeutics Group, Inc. Common Stock as of Q2 2024.

Based on Susquehanna International Group's 13F filing for Q2 2024, filed 15 Aug 2024.